Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of ...
Smith, a microbiologist whose discovery revolutionize the field of genetic engineering, was a Johns Hopkins School of Medicine alumnus and professor emeritus ...
Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by chemist Brian Liau and his collaborators at Harvard offers an ...
Explore how oligonucleotides are reshaping therapeutics, diagnostics and CRISPR with rapid, scalable and personalized ...
A new study has revealed that the gene HMGN1 is a key driver of congenital heart defects (CHDs) in Down syndrome. Using ...
Xenotransplantation is the fusion energy of medicine. As the well-worn joke goes, it is the future—and always will be. But ...
Classical CRISPR systems use molecular scissors to snip through DNA ... pulmonary arterial hypertension and HIV, as well as ...
The Division of Neuropathology is a cornerstone of the Department of Pathology, with its historical championing of human ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
BERKELEY, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced its first ...
Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback